SimpleScreen CRC is indicated for adults 45 and up at average risk
— SimpleScreen CRC is indicated for adults 45 and up at average risk
July 27, 2026
• 2 min read
The FDA approved SimpleScreen CRC, a blood-based screening test for adults 45 years and older who are at average risk for colorectal cancer (CRC), Freenome announced.
SimpleScreen CRC joins Guardant Health's Shield test, which was the first approved blood-based screening option for CRC.
The FDA has approved a second blood-based colorectal cancer screening option for adults aged 45 years and older at average risk…
Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically…
New cases of colorectal cancer and deaths have been rising in younger adults since the mid-2000s
The American Cancer Society is adding some new testing options to its screening guideline for colorectal cancers – and for the…
New guidance contains appropriate caution but an insufficient implementation framework
Updated ACS guidance suggests use in those who decline other options
